
Overview
Elise Hitron is an Oncologist in Atlanta, Georgia. Dr. Hitron is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), and WT1-Related Wilms Tumor Syndromes.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Emory Winship Cancer Institute
Bradley Carthon is an Oncologist in Atlanta, Georgia. Dr. Carthon has been practicing medicine for over 21 years and is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Prostatectomy.
Emory Winship Cancer Institute
Mehmet Bilen is an Oncologist in Atlanta, Georgia. Dr. Bilen has been practicing medicine for over 18 years and is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Tissue Biopsy.
Piedmont Physicians Urology Atlanta
"Dr. Laungani is a board-certified urologist who specializes in adult urology and urologic oncology. He is fellowship-trained in minimally invasive surgery (MIS) and robotic urology. A Brooklyn native, he graduated cum laude from Brooklyn College and received his medical degree from the State University of New York Downstate College of Medicine in Brooklyn, New York. He completed his surgical internship and urology residency at Henry Ford Hospital in Detroit, Michigan, where he later earned a fellowship in minimally invasive and robotic surgery from the Vattikuti Urology Institute at Henry Ford Hospital under the guidance of Dr. Mani Menon. Dr. Laungani has numerous peer-reviewed publications on urological advances and robotics and has lectured and operated internationally, including Egypt, Malaysia and the Czech Republic. Dr. Laungani holds memberships in several professional organizations including the Endourological Society, the American Urological Association, the American Association of Clinical Urologists, the Georgia, Michigan and New York State Urologic Society, the Society of Robotic Surgery and the American Medical Association. Dr. Laungani maintains a strong interest in prostate cancer research and education though multiple studies and collaborations with Georgia Institute of Technology and Emory University. He serves as associate professor (adjunct) at Clark Atlanta University's Center for Cancer Research and Therapeutic Development. He has received numerous professional honors and recognition for his outstanding work and has also been featured on CNN's Medical News and local medical news for ""tweeting"" Live Robotic Surgery in the OR.". Dr. Laungani is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Ureterocele, Familial Prostate Cancer, Reconstructive Urology Surgery, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chromophobe Renal Cell CarcinomaMs. Hitron isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaMs. Hitron isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Ms. Hitron isAdvanced. Learn about Familial Wilms Tumor 2.
- Renal Cell Carcinoma (RCC)Ms. Hitron isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Wilms TumorMs. Hitron isAdvanced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesMs. Hitron isAdvanced. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- Bladder CancerMs. Hitron isExperienced. Learn about Bladder Cancer.
- Familial Pancreatic CancerMs. Hitron isExperienced. Learn about Familial Pancreatic Cancer.
- Familial Prostate CancerMs. Hitron isExperienced. Learn about Familial Prostate Cancer.
- Multiple MyelomaMs. Hitron isExperienced. Learn about Multiple Myeloma.
- Muscle Invasive Bladder CancerMs. Hitron isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerMs. Hitron isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.


